Abstract:Key PointsCNS remyelination is the regenerative process by which myelin sheaths are restored to demyelinated axons. Unlike the poor regeneration that occurs following neuronal injury, remyelination can occur as a spontaneous and efficient process in experimental models and many clinical conditions.Although remyelination can occur in multiple sclerosis (MS; a widely occurring demyelinating disease), it often fails, leaving axons demyelinated and vulnerable to degeneration. Recent studies have revealed the importance of the myelin sheath for maintaining axonal integrity and hence the importance of promoting remyelination in diseases such as MS as an effective means of neuroprotection.Remyelination is mediated by a population of adult neural stem cells that are widely distributed throughout the CNS and that are commonly referred to as oligodendrocyte precursor cells (OPCs). These cells respond to demyelination by activation, proliferation, migration and finally differentiation into remyelinating oligodendrocytes; it is the last of these processes that is most likely to fail in MS and leave areas of demyelination containing oligodendrocyte-lineage cells that are unable to fully differentiate.Remyelination is governed by a complex interaction of environmental signals and cell-intrinsic mechanisms that are triggered by the inflammatory response to injury. This response therefore has a key role in initiating remyelination. The network of signals that is involved in remyelination shows high levels of redundancy.In theory, remyelination can be enhanced either by promoting endogenous remyelination or by transplanting myelinating cells. The first approach, which may have a pharmacological basis, is especially attractive for diseases such as MS in which remyelination occurs and will involve either the antagonism of negative regulatory pathways and/or the enhancement of positive regulatory pathways.Cell therapy (transplantation) approaches to remyelination are expected to be of particular benefit for genetic demyelinating diseases in which there is an inherent defect in the oligodendrocyte lineage. Recent studies have provided proof-of-principle that human cells can be used to remyelinate the entire CNS in laboratory animal models.

Mechanisms of oligodendrocyte regeneration from ventricular-subventricular zone-derived progenitor cells in white matter diseases

Microglia Impede Oligodendrocyte Generation in Aged Brain

Recent updates on mechanisms of cell-cell interaction in oligodendrocyte regeneration after white matter injury

Oligodendrocyte progenitor programming and reprogramming: Toward myelin regeneration

Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis

Neuroprotection and neuroregeneration: roles for the white matter

Demyelinating processes in aging and stroke in the central nervous system and the prospect of treatment strategy

Mechanisms and repair strategies for white matter degeneration in CNS injury and diseases

Integrative Systems and Functional Analyses Reveal a Role of Dopaminergic Signaling in Myelin Pathogenesis.

Myelin-based inhibitors of oligodendrocyte myelination: clues from axonal growth and regeneration

Preventing production of new oligodendrocytes impairs remyelination and sustains behavioural deficits after demyelination

[Mechanisms Underlying Remyelination with Special Focus on Demyelination Models of Multiple Sclerosis].

Epigenetic regulation of oligodendrocyte myelination in developmental disorders and neurodegenerative diseases.

Novel roles of oligodendrocyte precursor cells in the developing and damaged brain

Extrinsic Factors Driving Oligodendrocyte Lineage Cell Progression in CNS Development and Injury

Regenerative Capacity of Macrophages for Remyelination

Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches

Regulation of Oligodendrocyte Functions: Targeting Lipid Metabolism and Extracellular Matrix for Myelin Repair

Robust Myelination of Regenerated Axons Induced by Combined Manipulations of GPR17 and Microglia

Remyelination in the CNS: from biology to therapy

Central nervous system regeneration: the roles of glial cells in the potential molecular mechanism underlying remyelination